ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Wei Wang
Matched on ORCID iD 0000-0001-6985-2234; OpenAlex author ID A5100391709. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Successful treatment of GEMOX regimen combined with nimotuzumab in the pancreatic cancer with wild KRAS and mutant BRCA: a report of two cases. Last author DOI 10.21037/acr-24-68↗
- Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response and Survival Prediction in Pancreatic Can… Co-author DOI 10.3390/ijms24043270↗
- MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis. Co-author DOI 10.1002/iub.2468↗
- High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep12991↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Puxiongzhi Wang · 1 shared paper, 2024 · strength 0.28
- Jian Wang · 1 shared paper, 2021 · strength 0.19
- Jia Dong · 1 shared paper, 2023 · strength 0.18
- Qingcai Meng · 1 shared paper, 2023 · strength 0.18
- Miaoyan Wei · 1 shared paper, 2023 · strength 0.18
- Bo Zhang · 1 shared paper, 2023 · strength 0.18
- Jie Hua · 1 shared paper, 2023 · strength 0.18
- Jin Xu · 1 shared paper, 2023 · strength 0.18
- Chen Liang · 1 shared paper, 2023 · strength 0.18
- Xianjun Yu · 1 shared paper, 2023 · strength 0.18
- Jianfei Huang · 1 shared paper, 2015 · strength 0.05
- Zhiwei Wang · 1 shared paper, 2015 · strength 0.05
- Xudong Wang · 1 shared paper, 2015 · strength 0.05
- Yuhua Lu · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.